Topamax Capsule, Coated Pellets
Product Images NDC 50458-647

9 FDA label images from Janssen Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Topamax (NDC 50458-647). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Topamax 01)

Chemical Structure (Topamax 01)
Chemical structure diagram of topiramate, the active ingredient in Topamax. The structure shows a sulfamate-substituted monosaccharide with multiple methyl groups and oxygen atoms in a ring formation.*
FDA Label Image

Figure 1 (Topamax 02)

Figure 1 (Topamax 02)
A line graph showing cumulative rates for time to first seizure over a 500-day period comparing Topamax 50 mg/day (N=234) and Topamax 400 mg/day (N=236). The Y-axis represents cumulative rates, and the X-axis shows time in days. Two curves indicate the differences in seizure rates between the two dosage groups, with a noted p-value of 0.0002.*
FDA Label Image

Figure 2 (Topamax 03)

Figure 2 (Topamax 03)
A bar graph comparing changes from baseline to double-blind phase in average monthly migraine period rate for Placebo, Topamax 50 mg/day, 100 mg/day, and 200 mg/day groups across two studies (Study 11 and Study 12). The graph shows decreasing migraine rates with increasing Topamax dosage, with statistical significance indicated for 100 mg/day and 200 mg/day doses.*
FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Principal Display Panel (25 mg Tablet Bottle Label)
Topamax 25 mg coated tablets label. The label shows the brand name Topamax with the generic name topiramate, indicating a 25 mg strength. It is labeled for oral use and prescription only, containing 60 tablets per bottle. The labeler is Janssen Pharmaceuticals, Inc. The label includes cautions for pharmacists to verify prescriptions and dispense accompanying medication guides, along with storage instructions and tablet appearance: round, coated, cream-colored tablets debossed with "OWN" and "25".*
FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Principal Display Panel (50 mg Tablet Bottle Label)
Topamax 50 mg coated tablets in a 60-tablet package from Janssen Pharmaceuticals, Inc. The label includes cautionary instructions to verify the prescription before dispensing and to provide a medication guide to the patient. Storage directions specify controlled room temperature and protection from moisture. The label features the NDC 50458-640-65.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
Topamax (topiramate) Tablets 100 mg coated oral tablets label by Janssen Pharmaceuticals, Inc. The carton contains 60 tablets. The label includes the NDC 50458-641-65, directions to verify the prescription before dispensing, pharmacist's instructions to dispense a medication guide with each patient, and storage instructions to keep at controlled room temperature and away from children.*
FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Principal Display Panel (200 mg Tablet Bottle Label)
Topamax (topiramate) Tablets 200 mg oral coated tablets packaging label. The label indicates the product contains 60 tablets, is prescription only, and is manufactured by Janssen Pharmaceuticals, Inc. It includes cautionary instructions for pharmacists and storage conditions. The label also shows the National Drug Code (NDC) 50458-642-65 and barcodes.*
FDA Label Image

Principal Display Panel (15 mg Capsule Bottle Label)

Principal Display Panel (15 mg Capsule Bottle Label)
Topamax 15 mg sprinkle capsules label showing the NDC 50458-647-65. The product is topiramate capsules in sprinkle form, with 15 mg strength. The label states Rx only and contains 60 capsules per package. Janssen Pharmaceuticals, Inc. is the manufacturer, and the label includes storage instructions and pharmacist dispensing guidance.*
FDA Label Image

Principal Display Panel (25 mg Capsule Bottle Label)

Principal Display Panel (25 mg Capsule Bottle Label)
Topamax 25 mg Sprinkle Capsules label by Janssen Pharmaceuticals, Inc. The label displays the proprietary name Topamax and generic name topiramate capsules. It indicates the dosage form as sprinkle capsules with a strength of 25 mg per capsule. The package contains 60 capsules. The label includes dispensing instructions for pharmacists and storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.